Please assess the completion status of the following clinical trial:

Trial Title: Multi-strain Probiotic in the Management of IBS-D

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Diagnosed case of IBS using Rome III criteria~2. Absence of red flag sign: anemia, fever, wt loss, per rectal bleeding, nocturnal frequency, family history of inflammatory bowel disease (IBD), cancer~3. Age 18-55 years~4. No probiotics used in prior 3 months.~5. Agreed not to start any other drug unless clinically indicated.~6. No antibiotics in previous 2 months of enrolment.~Exclusion Criteria:~1. Age\<18 or \>55 years~2. Previous treatment with probiotics within last 3 months~3. Pregnant or lactating females~4. Concurrent severe illness (Uncontrolled diabetes mellitus, Renal Dysfunction, Liver disease, hyper and hypothyroidism)~5. Chronic organic bowel disorders e.g. inflammatory bowel diseases, tuberculosis, Diverticular disease etc~6. Any previous gastrointestinal surgery

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: f

Study Arms:
- To assess the effect of multistrain probiotics on abdominal (Type: PLACEBO_COMPARATOR): To assess the effect of multistrain probiotics on abdominal pain using a validated symptom severity score in IBS patients.
- To assess the efficacy of a multistrain probiotic supplement (Type: PLACEBO_COMPARATOR): To assess the efficacy of a multistrain probiotic supplement as a treatment option for IBS in a tertiary referral centre

Based on this trial design, predict the completion outcome and termination type (if applicable).